Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining platelet-rich products, biomaterials, and bioactive substances may improve skin treatment, but more research is needed.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Korean hair is typically thicker with a slower growth rate, and treatments like Dutasteride are effective for male pattern hair loss without major side effects.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Platelet-rich plasma might help with skin aging, ulcers, and hair loss, but more research is needed to prove its effectiveness and safety.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

0.5% minoxidil mesotherapy is more effective and safe for hair growth in women with androgenetic alopecia than topical 2% minoxidil.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

LactoSporin cream reduces wrinkles and improves skin texture safely.

Adding Biotin to PRP doesn't improve hair regrowth.

The combination of finasteride and minoxidil is as safe and effective as minoxidil alone for improving hair growth in men.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Low-level light therapy significantly increased hair density and thickness in people with hair loss, but they didn't notice a difference.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

New treatment with Wnt proteins and growth factors safely increases hair thickness.

PRP injections can increase hair density in people with androgenic alopecia.